Kathy Bartoni

537 total citations
9 papers, 401 citations indexed

About

Kathy Bartoni is a scholar working on Epidemiology, Hematology and Oncology. According to data from OpenAlex, Kathy Bartoni has authored 9 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Hematology and 4 papers in Oncology. Recurrent topics in Kathy Bartoni's work include Cytomegalovirus and herpesvirus research (4 papers), Neonatal Health and Biochemistry (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Kathy Bartoni is often cited by papers focused on Cytomegalovirus and herpesvirus research (4 papers), Neonatal Health and Biochemistry (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Kathy Bartoni collaborates with scholars based in United States. Kathy Bartoni's co-authors include Drew J. Winston, Richard E. Champlin, Robert Peter Gale, Winston G. Ho, Cheng‐Hsien Lin, Miriam D. Budinger, Mary Territo, Gary J. Schiller, W. G. Ho and D. J. Winston and has published in prestigious journals such as Blood, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Kathy Bartoni

9 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy Bartoni United States 6 267 148 112 94 88 9 401
Per Ljungman Sweden 5 388 1.5× 72 0.5× 249 2.2× 159 1.7× 40 0.5× 5 484
Unell Riley United Kingdom 11 192 0.7× 94 0.6× 138 1.2× 95 1.0× 42 0.5× 19 369
Dana Jaffe United States 7 282 1.1× 116 0.8× 184 1.6× 174 1.9× 127 1.4× 7 498
Stefan Neuburger Germany 11 176 0.7× 163 1.1× 145 1.3× 138 1.5× 41 0.5× 14 502
Marta Peracchi Italy 9 199 0.7× 40 0.3× 101 0.9× 74 0.8× 60 0.7× 15 328
Beverly Heinze-Lacey United States 4 459 1.7× 36 0.2× 131 1.2× 79 0.8× 87 1.0× 6 530
Leigh H. Fisher United States 8 218 0.8× 175 1.2× 115 1.0× 66 0.7× 50 0.6× 15 539
M Jaquet Herter Germany 3 331 1.2× 85 0.6× 76 0.7× 102 1.1× 69 0.8× 6 404
Judson Heugel United States 5 351 1.3× 48 0.3× 207 1.8× 74 0.8× 23 0.3× 8 442
Gilhen Rodriguez United States 13 281 1.1× 70 0.5× 189 1.7× 138 1.5× 78 0.9× 21 445

Countries citing papers authored by Kathy Bartoni

Since Specialization
Citations

This map shows the geographic impact of Kathy Bartoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Bartoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Bartoni more than expected).

Fields of papers citing papers by Kathy Bartoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Bartoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Bartoni. The network helps show where Kathy Bartoni may publish in the future.

Co-authorship network of co-authors of Kathy Bartoni

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Bartoni. A scholar is included among the top collaborators of Kathy Bartoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Bartoni. Kathy Bartoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Winston, Drew J., Kathy Bartoni, Mary Territo, & Gary J. Schiller. (2010). Efficacy, Safety, and Breakthrough Infections Associated with Standard Long-Term Posaconazole Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation Recipients. Biology of Blood and Marrow Transplantation. 17(4). 507–515. 56 indexed citations
2.
Schiller, Gary J., Kathy Bartoni, Bahru Habtemariam, et al.. (2008). 176: Phase I/II Trial of Bortezomib Maintenance following Autologous Peripheral Blood Progenitor Cell Transplantation as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma. Biology of Blood and Marrow Transplantation. 14(2). 65–65. 5 indexed citations
3.
4.
5.
Winston, Drew J., Kathy Bartoni, David A. Bruckner, Gary J. Schiller, & Mary Territo. (1998). Randomized Comparison of Sulbactam/Cefoperazone with Imipenem as Empirical Monotherapy for Febrile Granulocytopenic Patients. Clinical Infectious Diseases. 26(3). 576–583. 25 indexed citations
6.
Winston, D. J., W. G. Ho, Kathy Bartoni, & Richard E. Champlin. (1993). Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.. PubMed. 12(3). 283–8. 28 indexed citations
7.
Winston, Drew J., Winston G. Ho, Kathy Bartoni, et al.. (1988). Ganciclovir Therapy for Cytomegalovirus Infections in Recipients of Bone Marrow Transplants and Other Immunosuppressed Patients. Clinical Infectious Diseases. 10(Supplement_3). S547–S553. 49 indexed citations
8.
Winston, Drew J., Winston G. Ho, Cheng‐Hsien Lin, et al.. (1987). Intravenous Immune Globulin for Prevention of Cytomegalovirus Infection and Interstitial Pneumonia After Bone Marrow Transplantation. Annals of Internal Medicine. 106(1). 12–18. 228 indexed citations
9.
Winston, D. J., W. G. Ho, Kathy Bartoni, et al.. (1985). [Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation].. PubMed. 13(6). 296–301. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Per Ljungman Breakdown of academic impact, for papers by Unell Riley Breakdown of academic impact, for papers by Dana Jaffe Breakdown of academic impact, for papers by Stefan Neuburger Breakdown of academic impact, for papers by Marta Peracchi Breakdown of academic impact, for papers by Beverly Heinze-Lacey Breakdown of academic impact, for papers by Leigh H. Fisher Breakdown of academic impact, for papers by M Jaquet Herter Breakdown of academic impact, for papers by Judson Heugel Breakdown of academic impact, for papers by Gilhen Rodriguez
Rankless by CCL
2026